TORNTPHARM.NS Cash Flow
Torrent Pharmaceuticals Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 00:34
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹2,368.00 Cr. | ₹3,266.00 Cr. | ₹2,585.00 Cr. | ₹3,023.00 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-2,356.00 Cr. | ₹-168.00 Cr. | ₹-540.00 Cr. | ₹-12,713.00 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹77.00 Cr. | ₹-2,779.00 Cr. | ₹-2,298.00 Cr. | ₹10,151.00 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹21.00 Cr. | ₹8.00 Cr. | ₹-9.00 Cr. | ₹83.00 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹110.00 Cr. | ₹327.00 Cr. | ₹-262.00 Cr. | ₹544.00 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹398.00 Cr. | ₹508.00 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from TORNTPHARM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).